What is Vertex Pharmaceuticals's current net income?

The latest figure on the record is $653.6 million for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $3.95 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026.

What was Vertex Pharmaceuticals's net income for the quarter ended September 30, 2026?

$653.6 million for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95).

When did Vertex Pharmaceuticals's net income last change?

The latest value on the record is $3.95 billion, dated December 31, 2025; before it the record holds -$535.6 million, dated December 31, 2024 and closed on December 31, 2025.

What was Vertex Pharmaceuticals's net income before $3.95 billion?

-$535.6 million, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

organization · fact

Vertex Pharmaceuticals net income

As of November 9, 2026, the latest net income figure on the AsOf record for Vertex Pharmaceuticals is $653.6 million for the quarter ended September 30, 2026, from a primary source (sec.gov). Vertex Pharmaceuticals's latest full-year net income is $3.95 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared.

latest net income: $653.6 millionthe quarter ended September 30, 2026 · 1 source
full-year net income: $3.95 billionDecember 31, 2025 · 1 source

17 dated values, oldest first; the current one in colour. In United States dollar.

Every dated value

17 values · 1 current · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →

Vertex Pharmaceuticals net income: every dated value on the record, oldest first, with its dates, status, confidence and sources
value	valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →	valid to	confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →	sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
-$642.18 million: net income -642,178,000 United States dollar from 2009-12-31, claim clm_25D63D0ED4EF and its sources (superseded) to 2010-12-31 · sec.gov	2009-12-31	2010-12-31	0.95	sec.gov
-$754.63 million: net income -754,626,000 United States dollar from 2010-12-31, claim clm_6694DF685051 and its sources (superseded) to 2011-12-31 · sec.gov	2010-12-31	2011-12-31	0.95	sec.gov
$29.57 million: net income 29,574,000 United States dollar from 2011-12-31, claim clm_D6D7CB158831 and its sources (superseded) to 2012-12-31 · sec.gov	2011-12-31	2012-12-31	0.95	sec.gov
-$107.03 million: net income -107,032,000 United States dollar from 2012-12-31, claim clm_117D40256E77 and its sources (superseded) to 2013-12-31 · sec.gov	2012-12-31	2013-12-31	0.95	sec.gov
-$445.03 million: net income -445,028,000 United States dollar from 2013-12-31, claim clm_59D5E0CC1F00 and its sources (superseded) to 2014-12-31 · sec.gov	2013-12-31	2014-12-31	0.95	sec.gov
-$738.56 million: net income -738,555,000 United States dollar from 2014-12-31, claim clm_E0C813E29FDB and its sources (superseded) to 2015-12-31 · sec.gov	2014-12-31	2015-12-31	0.95	sec.gov
-$556.33 million: net income -556,334,000 United States dollar from 2015-12-31, claim clm_3CC906E153DA and its sources (superseded) to 2016-12-31 · sec.gov	2015-12-31	2016-12-31	0.95	sec.gov
-$112.05 million: net income -112,052,000 United States dollar from 2016-12-31, claim clm_2BC71558F3C9 and its sources (superseded) to 2017-12-31 · sec.gov	2016-12-31	2017-12-31	0.95	sec.gov
$263.48 million: net income 263,484,000 United States dollar from 2017-12-31, claim clm_EAA313C25D3D and its sources (superseded) to 2018-12-31 · sec.gov	2017-12-31	2018-12-31	0.95	sec.gov
$2.1 billion: net income 2,096,896,000 United States dollar from 2018-12-31, claim clm_D3A2B88BD1F9 and its sources (superseded) to 2019-12-31 · sec.gov	2018-12-31	2019-12-31	0.95	sec.gov
$1.18 billion: net income 1,176,810,000 United States dollar from 2019-12-31, claim clm_FE5B5CF4FB84 and its sources (superseded) to 2020-12-31 · sec.gov	2019-12-31	2020-12-31	0.95	sec.gov
$2.71 billion: net income 2,711,647,000 United States dollar from 2020-12-31, claim clm_79102BFD0743 and its sources (superseded) to 2021-12-31 · sec.gov	2020-12-31	2021-12-31	0.95	sec.gov
$2.34 billion: net income 2,342,100,000 United States dollar from 2021-12-31, claim clm_F3A2B9FC81F1 and its sources (superseded) to 2022-12-31 · sec.gov	2021-12-31	2022-12-31	0.95	sec.gov
$3.32 billion: net income 3,322,000,000 United States dollar from 2022-12-31, claim clm_1B7C3640D846 and its sources (superseded) to 2023-12-31 · sec.gov	2022-12-31	2023-12-31	0.95	sec.gov
$3.62 billion: net income 3,619,600,000 United States dollar from 2023-12-31, claim clm_DD75AE2A6FF1 and its sources (superseded) to 2024-12-31 · sec.gov	2023-12-31	2024-12-31	0.95	sec.gov
-$535.6 million: net income -535,600,000 United States dollar from 2024-12-31, claim clm_B3A7B0C585DF and its sources (superseded) to 2025-12-31 · sec.gov	2024-12-31	2025-12-31	0.95	sec.gov
$3.95 billion: net income 3,953,200,000 United States dollar from 2025-12-31, claim clm_406C31565DD9 and its sources to present · sec.gov	2025-12-31	present	0.95	sec.gov

What replaced what

16 replacements

-$642.18 million2009-12-31 to 2010-12-31→-$754.63 millionfrom 2010-12-31
-$754.63 million2010-12-31 to 2011-12-31→$29.57 millionfrom 2011-12-31
$29.57 million2011-12-31 to 2012-12-31→-$107.03 millionfrom 2012-12-31
-$107.03 million2012-12-31 to 2013-12-31→-$445.03 millionfrom 2013-12-31
-$445.03 million2013-12-31 to 2014-12-31→-$738.56 millionfrom 2014-12-31
-$738.56 million2014-12-31 to 2015-12-31→-$556.33 millionfrom 2015-12-31
-$556.33 million2015-12-31 to 2016-12-31→-$112.05 millionfrom 2016-12-31
-$112.05 million2016-12-31 to 2017-12-31→$263.48 millionfrom 2017-12-31
$263.48 million2017-12-31 to 2018-12-31→$2.1 billionfrom 2018-12-31
$2.1 billion2018-12-31 to 2019-12-31→$1.18 billionfrom 2019-12-31
$1.18 billion2019-12-31 to 2020-12-31→$2.71 billionfrom 2020-12-31
$2.71 billion2020-12-31 to 2021-12-31→$2.34 billionfrom 2021-12-31
$2.34 billion2021-12-31 to 2022-12-31→$3.32 billionfrom 2022-12-31
$3.32 billion2022-12-31 to 2023-12-31→$3.62 billionfrom 2023-12-31
$3.62 billion2023-12-31 to 2024-12-31→-$535.6 millionfrom 2024-12-31
-$535.6 million2024-12-31 to 2025-12-31→$3.95 billionfrom 2025-12-31

Questions this record answers

What is Vertex Pharmaceuticals's current net income?: The latest figure on the record is $653.6 million for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $3.95 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026.
What was Vertex Pharmaceuticals's net income for the quarter ended September 30, 2026?: $653.6 million for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95).
When did Vertex Pharmaceuticals's net income last change?: The latest value on the record is $3.95 billion, dated December 31, 2025; before it the record holds -$535.6 million, dated December 31, 2024 and closed on December 31, 2025.
What was Vertex Pharmaceuticals's net income before $3.95 billion?: -$535.6 million, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov).

Answered from the rows above, as of November 9, 2026.

Cite Vertex Pharmaceuticals net income

Each form names the value, its as-of date (2026-09-30), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text

AsOf. "Vertex Pharmaceuticals quarterly net income: 653,600,000 United States dollar", as of 2026-09-30. Claim clm_466B90DBA1DE, https://asof.is/claim/clm_466B90DBA1DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm.

APA

AsOf. (2026). Vertex Pharmaceuticals quarterly net income: 653,600,000 United States dollar (as of 2026-09-30) [Record clm_466B90DBA1DE]. Retrieved November 9, 2026, from https://asof.is/claim/clm_466B90DBA1DE (source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm)

BibTeX

@misc{asof_clm_466B90DBA1DE,
  author = {AsOf},
  title = {Vertex Pharmaceuticals quarterly net income: 653,600,000 United States dollar},
  year = {2026},
  howpublished = {\url{https://asof.is/claim/clm_466B90DBA1DE}},
  note = {Claim clm\_466B90DBA1DE, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm},
  urldate = {2026-11-09}
}

Read on

/record/vertex-pharmaceuticals/net_income.md · this page as markdown
/facts/net_income · every company's net income
/record/vertex-pharmaceuticals · /timelines/vertex-pharmaceuticals

Other facts about Vertex Pharmaceuticals

Record